MEDPACE HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 395.9 USD | +1.58% |
|
+6.43% | +29.17% |
| Apr. 24 | Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating | MT |
| Apr. 23 | Transcript : Medpace Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024 |
Chart calendar Medpace Holdings, Inc.
7e8fda.xRemhV6bBvAoxH56XBVgiLgOy9_5qeG80ep2jcotFxQ.g0PM_Rj4V69ulRkDLG0WwNw7-bPAzIOKmq4mxvNUWFioXcWoF_dsk0T3HQ~95da5ba89dd97aaeeb2fd7e547b48a60
Upcoming events on Medpace Holdings, Inc.
Past events on Medpace Holdings, Inc.
| 2024-04-23 09:00 am | Q1 2024 Earnings Call |
| 2024-04-22 04:15 pm | Q1 2024 Earnings Release |
| 2024-02-13 09:00 am | Q4 2023 Earnings Call |
| 2024-02-12 04:15 pm | Q4 2023 Earnings Release |
| 2023-10-24 09:00 am | Q3 2023 Earnings Call |
| 2023-10-23 04:15 pm | Q3 2023 Earnings Release |
| 2023-07-25 09:00 am | Q2 2023 Earnings Call |
| 2023-07-24 04:15 pm | Q2 2023 Earnings Release |
| 2023-05-19 09:00 am | Annual General Meeting |
| 2023-04-25 09:00 am | Q1 2023 Earnings Call |
| 2023-04-24 04:15 pm | Q1 2023 Earnings Release |
| 2023-02-14 09:00 am | FY 2022 Earnings Call |
| 2023-02-13 04:56 pm | FY 2022 Earnings Release |
| 2022-10-25 09:00 am | Q3 2022 Earnings Call |
| 2022-10-24 04:15 pm | Q3 2022 Earnings Release |
| 2022-07-26 09:00 am | Interim 2022 Earnings Call |
| 2022-07-25 04:15 pm | Interim 2022 Earnings Release |
| 2022-05-20 09:00 am | Annual General Meeting |
| 2022-04-26 09:00 am | Q1 2022 Earnings Call |
| 2022-04-25 04:15 pm | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 861 852 1.04% | 926 912 1.5% | 1 142 1 143 -0.04% | 1 460 1 452 0.55% | 1 886 1 886 0.01% | 2 171 |
|
EBITDA Million USD | Released Forecast Spread | 150 147 1.75% | 188 186 0.88% | 223 220 1.25% | 308 307 0.52% | 362 358 1.3% | 430 |
|
EBIT Million USD | Released Forecast Spread | 141 136 3.93% | 176 167 5.47% | 207 198 4.37% | 286 278 2.7% | 338 332 1.78% | 400 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 125 124 0.96% | 169 167 1.18% | 202 199 1.33% | 283 281 0.69% | 336 330 1.85% | 426 |
|
Net income Million USD | Released Forecast Spread | 100 97,0 3.51% | 145 141 2.91% | 182 179 1.71% | 245 235 4.5% | 283 275 2.99% | 360 |
|
EPS USD | Released Forecast Spread | 2,67 2,58 3.49% | 3,84 3,74 2.58% | 4,81 4,75 1.32% | 7,28 6,98 4.37% | 8,88 8,63 2.86% | 11,2 |
| Announcement Date | 24/02/20 | 15/02/21 | 14/02/22 | 13/02/23 | 12/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 331 327 1.18% | 351 344 2.09% | 384 357 7.44% | 394 386 2.07% | 434 403 7.76% | 461 434 6.27% | 492 476 3.52% | 498 498 0.13% | 511 512 -0.19% | 529 | 555 | 572 | 595 | 619 |
|
EBITDA Million USD | Released Forecast Spread | 70,4 60,8 15.68% | 68,1 61,8 10.13% | 89,3 65,4 36.45% | 80,4 78,6 2.28% | 92,8 78,5 18.32% | 83,6 82,4 1.44% | 90,2 86,5 4.22% | 95,8 91,7 4.49% | 116 98,4 17.5% | 101 | 106 | 110 | 123 | 120 |
|
EBIT Million USD | Released Forecast Spread | 66,1 54,7 20.86% | 63,4 55,4 14.49% | 84,3 59,4 42.01% | 74,5 72,3 3.04% | 87,4 71,9 21.69% | 77,7 76,0 2.25% | 83,9 79,9 4.97% | 89,4 84,7 5.6% | 109 91,6 19.03% | 94,2 | 99,1 | 103 | 113 | 112 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 65,3 55,0 18.78% | 62,0 56,1 10.51% | 81,9 58,4 40.28% | 73,6 71,6 2.91% | 86,0 72,3 18.95% | 75,7 75,5 0.29% | 83,2 79,9 4.18% | 90,7 85,2 6.43% | 113 94,8 18.99% | 99,3 | 105 | 110 | 120 | 119 |
|
Net income Million USD | Released Forecast Spread | 61,3 47,1 30.14% | 49,4 45,7 8.05% | 66,0 48,3 36.64% | 68,7 58,2 17.98% | 72,9 59,1 23.44% | 61,1 60,9 0.22% | 70,6 64,8 8.9% | 78,3 70,3 11.32% | 103 79,1 29.68% | 81,9 | 86,6 | 90,5 | 100 | 98,9 |
|
EPS USD | Released Forecast Spread | 1,69 1,26 34.13% | 1,46 1,31 11.28% | 2,05 1,48 38.75% | 2,12 1,79 18.44% | 2,27 1,82 25.07% | 1,93 1,91 0.85% | 2,22 2,05 8.52% | 2,46 2,22 10.75% | 3,20 2,47 29.79% | 2,53 | 2,69 | 2,81 | 3,19 | 3,08 |
| Announcement Date | 25/04/22 | 25/07/22 | 24/10/22 | 13/02/23 | 24/04/23 | 24/07/23 | 23/10/23 | 12/02/24 | 22/04/24 | - | - | - | - | - |
More events
Past sector events for Medpace Holdings, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MEDP Stock
- Calendar Medpace Holdings, Inc.
